[1] 汪倩, 徐瑞娟, 杨劲. 对乙酰氨基酚肝毒性机理及药物干预靶点. 药学与临床研究, 2011, 19:247-252. [2] Mcgill MR, Jaeschke H. MicroRNAs as signaling mediators and biomarkers of drug- and chemical-induced liver injury. J Clin Med, 2015,4:1063-1078. [3] 明雅南, 李春敏, 张静怡等. 对乙酰氨基酚诱导急性肝衰竭小鼠动物模型的建立. 肝脏, 2016, 21:351-354. [4] Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A, 2009,106:4402-4407. [5] Mcgill MR, Staggs VS, Sharpe MR, et al. Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome. Hepatology, 2015,60:1336-1345. [6] Liu X, Li J, Qin F, et al. miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer. Oncol Lett, 2016,11:3911-3916. [7] Fukushima T, Hamada Y, Yamada H, et al. Changes of micro-RNA expression in rat liver treated by acetaminophen or carbon tetrachloride--regulating role of micro-RNA for RNA expre-ssion. J Toxicol Sci, 2007,32:401-409. [8] Bolleyn J, Fraczek J, Vinken M, et al. Effect of Trichostatin A on miRNA expression in cultures of primary rat hepatocytes. Toxicol In Vitro, 2011,25:1173-1182. [9] Hoefig KP, Heissmeyer V. MicroRNAs grow up in the immune system. Curr Opin Immunol, 2008,20:281-287. [10] Arrese M, Eguchi A, Feldstein AE. Circulating microRNAs: emerging biomarkers of liver disease. Semin Liver Dis, 2015, 35:43-54. |